By rapidly recruiting alternative pathways around occluded vessels, BPC-157 addresses the consequences of thrombosis without necessarily dissolving the clot itself
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials
Stimuli-Responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy
Seo M-D, Kang TJ, Lee CH, Lee A-Y, Noh M
Improvement of kidney redox states contributes to the beneficial effects of dietary pomegranate peel against barium chloride-induced nephrotoxicity in adult rats
Latest in Health Hub The latest articles in BioCeuticals health hub feature up-to-date research and expert insights on emerging health trends, offering valuable information on topics such as immune support, gut health, and stress management